A bio-inspired supramolecular protein gel that regenerates dental enamel by triggering the epitaxial growth of apatite nanocrystals. This clinically friendly technology restores the natural structure, stiffness, and wear resistance of enamel and dentine, offering a transformative solution for treating erosion and hypersensitivity.
This technology is a biomimetic, supramolecular protein matrix designed to regenerate human dental enamel. By emulating the natural, disordered protein environment found during enamel development, this matrix provides a scaffold that facilitates the growth of organized apatite nanocrystals. It addresses the critical clinical challenge of enamel loss, offering a way to regrow microstructured tissue that mimics the original, healthy enamel.
The technology is currently at TRL 4-5. It has been successfully demonstrated in ex vivo studies and is being transitioned toward clinical application through the university-supported start-up company, Mintech-Bio, with initial product development ongoing.
The University of Strathclyde is a public research university in Glasgow, recognised as an international technological university. Industry collaboration is built into the campus through the Technology & Innovation Centre, where companies and researchers work in co‑located labs. System‑scale testing is enabled by the Power Networks Demonstration Centre, while access to the National Manufacturing Institute Scotland provides industrial‑grade facilities and skills development. Anchoring the Glasgow City Innovation District and hosting the Fraunhofer Centre for Applied Photonics, Strathclyde offers direct routes from discovery to deployment; research is backed by UKRI funding, including EPSRC and Innovate UK, with commercialization supported by a technology transfer office and Strathclyde Inspire.